Research Article
[Retracted] Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study
Table 3
Survival outcomes in each cancer type.
| Primary organ affected | No. of Patients | Male | Female | Survived at least 1 year | Survived at least 2 years | Survived at least 3 years | Survived at least 4 years | Survived at least 5 years |
| Stomach | 42 | 22 | 20 | 34 | 24 | 21 | 20 | 16 (38.1%) | G. Bladder | 40 | 21 | 19 | 32 | 25 | 20 | 18 | 15 (37.5%) | Pancreas | 44 | 24 | 20 | 34 | 28 | 27 | 21 | 17 (38.64%) | Liver | 32 | 17 | 15 | 26 | 22 | 19 | 17 | 14 (43.75%) |
|
|